Market Tracker

07/23 11:27am ET

Impax Laboratories Inc (NASDAQ:IPXL)

29.08
Real-Time Quote
 +0.07 / +0.24%
Today’s Change
19.39
Today|||52-Week Range
31.04
+15.67%
Year-to-Date

Today’s Trading

Previous close29.01
Today’s open29.10
Day’s range28.95 - 29.17
Volume348,672
Average volume (3 months)633,322
Market cap$2.0B
Dividend yield--
Data as of 11:12am ET, 07/23/2014

Growth & Valuation

Earnings growth (last year)+79.27%
Earnings growth (this year)+10.15%
Earnings growth (next 5 years)+31.11%
Revenue growth (last year)-12.07%
P/E ratio1,455.0
Price/Sales3.29
Price/Book2.50

Competitors

 Today’s
change
Today’s
% change
IRWDIronwood Pharmaceuti...+0.53+3.66%
ACADACADIA Pharmaceutica...+0.58+2.88%
PBYIPuma Biotechnology I...+164.22+278.20%
WXWuXi Pharmatech (Cay...+0.28+0.87%
Data as of 11:27am ET, 07/23/2014

Financials

Next reporting dateAugust 6, 2014
EPS forecast (this quarter)$0.37
Annual revenue (last year)$511.5M
Annual profit (last year)$101.3M
Net profit margin19.80%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
President &
Chief Executive Officer
George Frederick Wilkinson
Chief Financial Officer &
Senior VP-Finance
Bryan M. Reasons
Corporate headquarters
Hayward, California

Forecasts